Therapy News and Research

RSS

Ori Biotech and CellGenix to collaborate in order to promote innovation within closed-system cell and gene therapy manufacturing

Ori Biotech Ltd announced a partnership to achieve closed-system preparation and the addition of CellGenix media and growth factors within CGT manufacturing.

14 May 2020

Low albumin levels could predict poor outcome in COVID-19

A Spanish study has revealed that COVID-19 patients who have a low level of albumin have a poorer outcome compared to those with normal levels of blood albumin. The study titled, “Low albumin levels are associated with poorer outcomes in a case series of COVID-19 patients in Spain: a retrospective cohort study,” was released prior to peer-review on the open-access preprint server site Medrxiv*.

13 May 2020

MRI reveals signs of fetal alcohol syndrome in the womb

New images reveal the earliest impairments to nonhuman primate fetal brain development due to alcohol ingested by the mother, in a study led by scientists at Oregon Health & Science University involving rhesus macaques.

13 May 2020

New treatment improves survival for people with common liver cancer

For the first time in over a decade, scientists have identified a first-line treatment that significantly improves survival for people with hepatocellular carcinoma, the most common type of liver cancer.

13 May 2020

Study shows 19 out of 25 COVID-19 patients improved with convalescent plasma treatment

The country's first convalescent plasma transfusion trial results have been published and show 19 out of 25 patients improved with the treatment, and 11 were discharged from the hospital.

13 May 2020

Does HIV infection increase the severity of COVID-19?

A new study by researchers at the New York University Grossman School of Medicine and published on the preprint server medRxiv* in May 2020 reports that being infected with HIV at the time of acquiring COVID-19 does not significantly increase the severity of illness or the risk of complications.

13 May 2020

Trial E3311: Less intense treatment for HPV+ oropharynx cancer shows positive results

The final results of the randomized phase two trial E3311 will be presented at the American Society of Clinical Oncology annual meeting, to occur virtually from May 29-31.

13 May 2020

Adding eccentric exercises could improve outcomes for people with ACL injuries

People with anterior cruciate ligament injuries can lose up to 40% of the muscle strength in the affected leg--with muscle atrophy remaining a big problem even after ACL reconstruction and physical therapy.

13 May 2020

Developing innovative radiation treatment for inoperable brain and spinal tumors

An innovative radiation treatment that could one day be a valuable addition to conventional radiation therapy for inoperable brain and spinal tumors is a step closer, thanks to new research led by University of Saskatchewan (USask) researchers at the Canadian Light Source (CLS).

13 May 2020

Research explores how COVID-19 is spreading and mutating in the environment

A multi-disciplinary team of experts in virology and computer modeling has quickly assembled at San Diego State University to learn more about how the new coronavirus (COVID-19) spreads in the environment and how its trajectory can be better predicted.

13 May 2020

Study refutes link between anti-hormonal breast cancer therapy and rheumatoid arthritis risk

Breast cancer patients do not have an increased risk of developing rheumatoid arthritis. A Swedish cohort study has now come to this conclusion.

13 May 2020

Nomograms can predict the risk of treatment delays for head and neck cancer patients

More than 65,000 Americans are diagnosed annually with head and neck cancer, which most often occurs inside the mouth and throat. For patients who undergo surgery to treat this cancer, guidelines recommend that prompt initiation of radiotherapy -- within six weeks -- is critical for best outcomes.

13 May 2020

Internet-delivered CBT just as effective as face-to-face treatment for health anxiety

Researchers at Karolinska Institutet in Sweden have compared two ways of delivering cognitive behavioral therapy, CBT, to treat people with health anxiety, a condition that may increase in the wake of COVID-19.

13 May 2020

Harnessing the formation of natural killer–tumor cell immunological synapse to treat solid cancers

There are immune cells in our bodies that directly destroy infected or cancer cells - they are called natural killer cells. Recently, a POSTECH research team has developed an integrative cancer therapy using adoptive natural killer cell therapy and chemotherapy.

13 May 2020

App to treat migraines without the use of medication

One in seven people suffer from migraines and one in a hundred experience chronic headaches. Painful headaches can destroy a person's social life and interfere with their ability to be a part of the workforce. Traditional migraine medication helps some individuals but has frequent side effects.

13 May 2020

Research identifies a disease trigger for pancreatitis

One factor contributing to the development of pancreatitis lies in mutations within a cell membrane ion channel that is characterized by its specific permeability for calcium ions.

13 May 2020

Study shows why older individuals are vulnerable to COVID-19

A group of tiny RNA that should attack the virus causing COVID-19 when it tries to infect the body are diminished with age and chronic health problems, a decrease that likely helps explain why older individuals and those with preexisting medical conditions are vulnerable populations, investigators report.

13 May 2020

Experts review symptoms, diagnosis, and current treatment of COVID-19

The ongoing economic and social impact of the pandemic is staggering, but despite a daily flood of news on the disease, few laypeople know that paradoxically, COVID-19 mostly kills through an overreaction of the immune system, whose function is precisely to fight infections.

13 May 2020

Processes underlying the damaging effects of brain injury can preserve memory function

A study examining the effect of the immune receptor known as Toll-like Receptor 4, or TLR4, on how memory functions in both the normal and injured brain has found vastly different cellular pathways contribute to the receptor's effects on excitability in the uninjured and injured brain.

13 May 2020

Study: Surgical patients appear to recover faster than patients treated with functional bracing

Surgical patients appear to recover faster and more reliably than patients treated with functional bracing.

13 May 2020

Therapy News and Research

Ori Biotech and CellGenix to collaborate in order to promote innovation within closed-system cell and gene therapy manufacturing

Low albumin levels could predict poor outcome in COVID-19

MRI reveals signs of fetal alcohol syndrome in the womb

New treatment improves survival for people with common liver cancer

Study shows 19 out of 25 COVID-19 patients improved with convalescent plasma treatment

Does HIV infection increase the severity of COVID-19?

Trial E3311: Less intense treatment for HPV+ oropharynx cancer shows positive results

Adding eccentric exercises could improve outcomes for people with ACL injuries

Developing innovative radiation treatment for inoperable brain and spinal tumors

Research explores how COVID-19 is spreading and mutating in the environment

Study refutes link between anti-hormonal breast cancer therapy and rheumatoid arthritis risk

Nomograms can predict the risk of treatment delays for head and neck cancer patients

Internet-delivered CBT just as effective as face-to-face treatment for health anxiety

Harnessing the formation of natural killer–tumor cell immunological synapse to treat solid cancers

App to treat migraines without the use of medication

Research identifies a disease trigger for pancreatitis

Study shows why older individuals are vulnerable to COVID-19

Experts review symptoms, diagnosis, and current treatment of COVID-19

Processes underlying the damaging effects of brain injury can preserve memory function

Study: Surgical patients appear to recover faster than patients treated with functional bracing

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News